Search

Venus Remedies

Sector: Healthcare | Industry: Drugs & Pharma
R 34.30 4.80  | 16.27% -12.05% - 42.21
NSE Price: Oct 18, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 15:58 34.30 4.80 16.27% 33.85 29.50 630,049 30.95 - 35.30
BSE Oct 18, 2019 34.20 5.15 17.73% 34.00 29.05 94,810 31.05 - 34.85
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 56,135 P/B: 0.13 NSE Code: VENUSREM
52-Week Range: R 18.80 - 68.00 Dividend Yield: 0.00% BSE Code: 526953
TTM EPS: R -20.45 Book Value: R 273.27 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Venus Remedies -21.74 47.10 60.94 -12.50 -35.24 -33.03 -17.14
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -13.57 -8.36 -9.88
Net Profit 6.90 -356.22 -185.03
EPS 6.90 -349.83 -183.75
Book Value -8.12 -11.02 -7.76
Average
Operating Margin 12.00 12.33 15.25
Net Margin -8.71 -7.04 -3.92
Return on Networth -8.23 -6.85 -3.81
Return on Investment -0.67 0.84 2.72
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -18.00 8.09 -18.00
Operating Profit 58.31 2.83 58.31
Net Profit 64.61 33.65 64.61
EPS 64.61 33.65 64.61
TTM
Revenue 1.76 -10.29 1.76
Operating Profit 0.73 2.04 0.73
Net Profit 6.90 13.30 6.90
EPS 6.90 13.30 6.90
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Venus Remedies 42.21 307.14 -25.24 -8.06 -8.23 0.13 -
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 16, 2015 Merrill Lynch capital Market Espana S A ,S V  Sell Market 45,144 162.55 73.38
Nov 26, 2014 Morgan Stenley Mauritius Company Ltd  Sell Market 38,392 222.50 85.42
Nov 11, 2014 Pawan Chaudhary  Sell Market 72,000 263.85 189.97
May 14, 2014 Sunev Pharma Solutions Ltd.  Sell - 25,000 309.60 77.40
May 13, 2014 Sunev Pharma Solutions Ltd.  Sell - 25 310.70 0.08
Fund Houses invested in the stock
Fund Dec-12 Sep-12 Jun-12 Mar-12 Dec-11
Sahara Mutual Fund 0.087 0.087 0.103 - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Venus Remedies Ltd.

Address: S.c.o. 857, C. No. 10, 2nd Floor, N A C Manimajra, Chandigarh, Chandigarh - 160101 | Phone: 91-0172- 2561244/5577 | Fax: 91-0172-2565566

Email: [email protected]

Website: www.venusremedies.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: Narang Tower 44, Community Centre,Naraina Industrial Area Phase - 1,New Delhi - 110 028, Narang Tower 44, Community Centre, Naraina Industrial Area, Phase - 1

Email: [email protected]

Essential checks
Altman Z-Score
1.09
Piotroski F-Score
5
Modified C-Score
2
5-Years Price to Earnings
Not applicable
5-Years Price to Book
0.13
Earnings Yield
EBIT / Enterprise value
-0.53%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59